Development and Characterization of Niosomal Gel System using Lallementia royaleana Benth. Mucilage for the Treatment of Rheumatoid Arthritis

Document Type : Research article


1 Meerut Institute of Engineering and Technology, Meerut (250005), Uttar Pradesh, India.

2 Department of Pharmaceutical Science, Shalom Institute of Health and Allied Sciences, SHUATS, Prayagraj (211007), Uttar Pradesh, India.


Niosomes structural framework comprises of non-ionic surfactant-based microscopic lamellar structures which carries the potential to sustain the effect of drug from its delivery system. In present work, the attempt was made to identify the effect of different ingredients such as effect of Tweens and natural mucilage of Lallemantia royaleana Benth. on the performance of developed niosomal gel formulations in order to prolong the duration of action of drug and to minimize its side effects of topical conventional drug administration. All Ibuprofen loaded niosomes formulationswere prepared by ether injection method; using cetosteryl alcohol with different variants of Tweens & Spans. Various evaluation parameters were performed to confirm niosome formation. Further, the niosomes were incorporated into gel system and evaluated for in-vitro permeability study (ex-vivo) on excised rat skin by membrane diffusion method and in-vivo study by carrageenan induced rat paw edema model.The best selected niosome formulation F9 gave no sedimentation, layer separation and unchanged particle shapes and thus selected for gel preparation using Lallemantia royaleana Benth. mucilage and carbopol in different ratios. Ex-vivo and in-vivo studies indicated high skin retention and penetration rates within the skin for tests niosomal gel formulations (G1 & G2). The present study suggested that developed topical gel formulation provides enhance permeability and longer duration of drug action over conventional gels.

Graphical Abstract

Development and Characterization of Niosomal Gel System using Lallementia royaleana Benth. Mucilage for the Treatment of Rheumatoid Arthritis


  • Firestein GS and McInnes Immunopathogenesis of Rheumatoid Arthritis. Immunity. (2017) 46: 183- 96.
  • McInnes IB andSchett G. The Pathogenesis of Rheumatoid Arthritis. Engl. J. Med. (2011) 365:2205-19.
  • Rainsford KD. Ibuprofen: pharmacology, efficacy, and Inflammopharmacology (2009) 17: 275- 342.
  • Bula D and Ghaly ES. Liposome delivery systems containing Ibuprofen. Drug Ind. Pharm. (1995) 21: 1621-9.
  • Janjikhel R and Adeyeye MC. Dissolution of Ibuprofen enantiomers from coprecipitates and suspensions containing chiral excipients. Dev. Technol. (1999) 4: 9-17.
  • Sharma N, Agarwal G, Rana AC, Bhat ZA and Kumar D. A review: transdermal drug delivery system: a tool for novel drug delivery system. J. Drug Dev. Res. (2011) 3: 70-84.
  • Bhowmik D, Chandira MC, Jayakar B and Sampath Recent advances in transdermal drug delivery system. Int. J. Pharm. Technol. (2010) 2: 68-77.
  • Handjani-Vila RM, Ribier A, Vanlerberghie G, Zabotto A and Griat J. Cosmetic and pharmaceutical compositions containing niosomes and a water- soluble polyamide, and a processfor preparing these compositions, L’Oréal. U S Patent No. 4830857. 1989.
  • Patel KK, Kumar P and Thakkar Formulation of Niosomal gel for enhanced transdermal Lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS PharmSciTech (2012) 13: 1502-10.
  • Asthana GS, Asthana A, Singh D and Sharma  Etodolac containing topical niosomal gel: formulation, development and evaluation. J. Drug Deliv. (2016) 2016: 1-8.
  • Zubairu Y, Negi LM, Iqbal Z and Talegaonkar

Design and development of novel bioadhesiveniosomal formulation for the transcorneal delivery of anti-infective agent: In- vitro and ex-vivo investigations. Asian J. Pharm. (2015) 10: 322-30.

  • Ramkanth S, Chetty MC, Sudhakar Y, Thiruvengadarajan VS, Anitha P and Gopinath C. Development, characterization and in-vivo evaluation of proniosomal based transdermal delivery system of Atenolol. Future J. Pharm. Sci. (2018) 4: 80-7.
  • Piplani P, Kumar P, Rohilla A, Singla S and Kaur Development and evaluation of an ocular niosomal delivery system for some newly synthesized Beta blockers. Asian J. Biomed. Pharm. Sci. (2014) 4: 8-17.
  • Kamboj S, Saini V, Bala S and Sharma G. Formulation and characterization of drug loaded niosomal gel for anti-inflammatory activity. J. Pharm. Pharm. Sci. (2013) 7: 877-81.
  • Srikanth K, Nappinhai M and Gupta VRM. Formulation and evaluation of topical meloxicam niosomal gel. J. Biopharm. (2010) 1: 7-13.
  • Rajera R, Nagpal K, Singh SK and Mishra DN. Niosomes: A controlled and novel drug delivery system. Pharm. Bull. (2011) 34: 945-53.
  • Sankar V, Ruckmani K, Jailani S, Ganesan K and Sharavanan Recent trends and developments: Niosome drug delivery system. Indian Pharm. (2010) 9: 16-8.
  • Malhotra M and Jain NK. Niosomes as drug carriers. Indian Drugs (1994) 31: 81-6.
  • Karim KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M and Kuotsu K. Niosome: A future of targeted drug delivery systems. Adv. Pharm. Technol. Res. (2010) 1: 374-80.
  • Biju SS, Talegaonkar S, Mishra PR and Khar RK. Vesicular systems: An overview, Indian J. Pharm. Sci. (2006) 8: 141-53.
  • Hao YM and Li K. Entrapment and release difference resulting from hydrogen bonding interactions in niosome. J. Pharm. (2011) 403: 245-53.
  • Marzio DL, Marianecci C,  Petrone  M,  Rinaldi  F and Carafa M. Novel pH-sensitive non-ionic surfactant vesicles: Comparison between Tween 21 and Tween Colloids Surf. B (2011) 82:18-24.
  • Vyas Theory and practice in novel drug delivery system. 1st ed. CBS Publishers and Distributors Pvt Ltd, New Delhi India (2009) 284-98.
  • Shirsand SB, Para MS, Nagendrakumar D, Kanani KM and Keerthy D. Formulation and evaluation of Ketoconazole niosomal gel drug delivery system. J. Pharm. Investig. (2012) 2: 201-7.
  • Naghibi F, Mosaddegh M, Mohammadi S and Ghorbani A. Labiatae family in folk medicine in Iran: from ethnobotany to pharmacology. J. Pharm. Res. (2005) 2: 63-79.
  • Khare Indian Medicinal Plants (An Illustrated Dictionary). 1st Ed. Springer Science and Business Media, New York; (2007), 360.
  • Preedy V, Whatson RR and Patel VB. Nuts and seeds in health and disease 1st Ed. Academic Press, USA (2011), 93.
  • Khan A, Siddiqui A, Jamal A and Fatima Lallemantia royaleana Benth. (Balangu): A compendious review on phytochemistry. pharmacology and ethnomedicinal uses. J. Drug Deliv. Ther. (2019) 9: 175-77.
  • Amin GR. Popular Medicinal Plants of Iran. Publications of Tehran University of Medical Sciences, Tehran (2005) 66-7.
  • Ghannadi A and Zolfaghari B. Compositional analysis of the essential oil of Lallemantia royleana (Benth. In ) Benth. From Iran. Flavour Frag. J. (2003) 18: 237-39.
  • Safa O, Soltanipoor MA, Rastegar S, Kazemi M, Nourbakhsh Dehkordi KH and Ghannadi A. An ethnobotanical survey on hormozgan province, Iran. Avicenna J. Phytomed. (2013) 3: 64-81.
  • Ali Esmail Al-Snafi. Pharmacological and therapeutic effects of Lallemantia Royleana- A review. IOSR J. Pharm. (2019) 9: 43-50.
  • Malavya BK and Dutt S. Chemical examination of the fixed oil derived from the seeds of Lallemantia royleana Benth Br. J. Nutr. (1941) 96: 1021- 9.
  • Mohammad Amini A and Razavi SMA. Dilute solution properties of Balangu (Lallemantia royleana) seed gum: Effect of temperature, salt and Int. J. Biol. Macromol. (2012) 51: 235-43.
  • Ali S, Parvez N and Sharma PK. Extraction and evaluation of Lallemantia royleana WJPPS (2016) 5: 1056-66.
  • Atabaki R and Hassanpour-Ezatti M. Improvement of lidocaine local anesthetic action using Lallemantia royleana seed mucilage as an Iran J. Pharm. Res. (2014) 13: 1431-6.
  • Bahramparvar M,  Hadad   Khodaparast   MH  and Amini AM. Effect of substitution of carboxymethylcellulose and salep gums with Lallemantia royaleana hydrocolloid on ice cream properties. Food Sci. Tech. Res. J. (2008) 4: 37-47.
  • Samadi S, Khaiyamiand M and Hasanzadeh Goorut Tappe A comparison of important physical and chemical characteristics of six Lallemantiaiberica (Bieb.) Fisch. And Mey. Varieties. Pak. J. Nutr. (2007) 6: 387-90.
  • Ghannadi A, Movahedian A, and Jannesary Hypocholesterolemic effects of Balangu (Lallemantia royleana) seeds in the rabbits fed on a cholesterol-containing diet. Avicenna J. Phytomed. (2015) 5: 167-73.
  • Deamer DW andBangham AD. Large volume liposomes by an ether vaporization method. Biophys. Acta (1976) 443: 629-34.
  • Shreedevi HM, Nesalin JAJ and Mani Development and evaluation of Stavudineniosome by ether injection method. Int. J. Pharm. Sci. Res. (2016) 7: 38-46.
  • Adeyeye MC and Brittain HG. Preformulation in solid Preformulation in Solid Dosage Form Development. New York: Informa Healthcare USA, Inc. 2008:279-321.
  • Evans WC. Trease and Evans’ 16th Ed., Saunders Ltd., Elsevier, Edinburgh, UK (2009): 563-570.
  • Castanho MARB, Santos NC andLoura LMS. Separating the turbidity spectra of vesicles from the absorption spectra of membrane probes and other chromophores. Biophys. J. (1997) 26: 253-9.
  • Aggarwal D and Kaur Improved pharmacodynamics of timolol maleate from a mucoadhesiveniosomal ophthalmic drug delivery system. Int. J. Pharm. (2005) 290: 155-9.
  • Ruckmani K, Jayakar B and Ghosal SK. Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in-vitro Drug Dev. Ind. Pharm. (2000) 26: 217-22.
  • El-Laithy HM, Shoukry OO and Mahran Novel sugar esters proniosomes for transdermal delivery of vinpocetine: Preclinical and clinical studies. Eur. J. Pharm. Biopharm. (2011) 77: 43-55.
  • Higuchi Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. (1963) 52: 1145-9.
  • Yang SC, Lu LF, Cai Y, Zhu JB, Liang BW and Yang Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. ‎J. Control. Release. (1999) 59: 299-307.
  • Mehrgan H and Mortazavi The release behavior and kinetic evaluation of diltiazemhcl from various hydrophilic and plastic based matrices. Iran J. Pharm. Res. (2005) 4: 137-46.
  • Lerk PC and Sucker H. Application of sucrose laurate in topical preparations of cyclosporin a. J. Pharm. (1993) 92: 203-10.
  • Tehrani MR and Mehramizi A. In-vitro release studies of piroxicam from oil-in-water creams and hydroalcoholic gel topical formulation. Drug Ind. Pharm. (2000) 26: 409-14.
  • Okyar A, Yildiz A, Aksu B, Çınar C, Ozsoy Y and Baktır Effect of terpenes as penetration enhancers on percutaneous penetration of Tiaprofenic acid through pig skin. Acta Pharm. Sci. (2008) 50: 247- 56.
  • Fang JY, Yu SY, Wu PC, Huang YB and Tsai In-vitro skin permeation of estradiol from various proniosome formulations. Int. J. Pharm. (2001) 215: 91-9.
  • Plessis J, Egbaria K and Weiner Influence of formulation factors on the deposition of liposomal components into the different strata of the skin. J. Soc. Cosmet. Chem. (1992) 43: 93-100.
  • Srikanth K, Nappinnai, M, Gupta, VRM and Suribabu, J. Niosomes: A prominent tool for transdermal drug delivery. J. Pharm. Biol. Chem. Sci. (2010) 1: 308-16.
  • Brattsand R, Thalen A,  Roempke  K,  Kallstrom L and Gruvstad E. Influence of 16α, 17α-acetal substitution and steroid nucleus fluorination on the topical to systemic activity ratio of J. Steroid Biochem. (1982) 16: 779-86.
  • Adhirajan N, Dixit VK andGowri C. Development and evaluation herbal formulations for hair growth. Indian Drugs (2001) 38: 559-63.
  • Sintov A, Zeevi A, Uzan R and Nyska Influence of pharmaceutical gel vehicles containing oleic acid/sodium oleate combinations on hairless mouse skin, a histological evaluation. Eur. J. Pharm. Biopharm. (1999) 47: 299-303.
  • Pardakhty A, Varshosaz J and Rouholamini A. In- vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J. Pharm. (2007) 328: 130-41.
  • Balakrishnan P, Shanmugama S, Lee WS, Lee WM, Kim JO, Oh DH, Kim DD, Kim JS, Yoo BK, Choi HG, Woo JS and Yonga Formulation and in-vitro assessment of minoxidilniosomes for enhanced skin delivery. Int. J. Pharm. (2009) 377: 1-8.
  • Liu T and Guo R. Preparation of a highly stable niosome and its hydrotropesolubilization action to Langmuir (2005) 21: 11034-9.
  • Ruckmani K and Sankar Formulation and optimization of Zidovudineniosomes. AAPS PharmSciTech (2010) 11: 1119-27.
  • Mohammed AR, Weston N, Coombes AGA, Fitzgerald M and Perrie Liposome formulation of poorly water soluble drugs: Optimization of drug loading and ESEM analysis of stability. Int. J. Pharm. (2004) 285: 23-34.
  • Uchegbu IF and Florence Non-ionic surfactant vesicles (niosomes): Physical and Pharmaceutical chemistry. Adv. Colloid Interface Sci. (1995) 58: 1-55.
  • Hasan AA, Madkor H and Wageh Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system. Drug Deliv. (2013) 20: 120-6.
  • Okore VC, Attama AA, Ofokansi KC, Esimone CO and Onuigbo EB. Formulation and evaluation of niosomes. Indian J. Pharm. Sci. (2011) 73: 323-8.
  • Uchegbu IF and Vyas Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int. J. Pharm. (1998) 172: 33-70.
  • Szuts A, Makai Z, Rajko R and Revesz PS. Study of the effects of drugs on the structures of sucrose esters and the effects of solid-state interactions on drug release. Pharm. Biomed. Anal. (2008) 48: 1136-42.
  • Abdulrasool AA, Naseer AA and Rahi Application of seed mucilage extracted from Lallemantia royaleana as a suspending agent. Iraqi J. Pharm. Sci. (2011) 20: 8-13.
  • Kirjavainen M, Urtti A, Koskela RV, Kiesvaara J and Monkkonen J. Liposome-skin interactions and their effects on the skin permeation of Eur. J. Pharm. Sci. (1999) 7: 279-86.
  • Shinde UA and Kanojiya SKS. Serratiopeptidaseniosomal gel with potential in topical delivery. Pharmaceutics (2014) 4: 1-9.